levobupivacaine has been researched along with Lung Injury, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, D; Li, K; Miao, Y; Yang, M; Zhang, H | 1 |
1 other study(ies) available for levobupivacaine and Lung Injury, Acute
| Article | Year |
|---|---|
Levobupivacaine attenuates lipopolysaccharide-induced acute lung injury.
Topics: A549 Cells; Acute Lung Injury; Anesthetics, Local; Animals; Anti-Inflammatory Agents; Bupivacaine; Dose-Response Relationship, Drug; Humans; Inflammation Mediators; Levobupivacaine; Lipopolysaccharides; Male; Random Allocation; Rats; Rats, Sprague-Dawley | 2016 |